| Literature DB >> 32735406 |
Marco Legnazzi1, Federica Agnello1, Davide Capodanno2.
Abstract
Intravascular administration of contrast media is an irreplaceable step of percutaneous coronary intervention. Since the latter is a very common procedure, contrast‑induced acute kidney injury (CI‑AKI) has become one of the most frequent causes of acute nephropathy, and a relevant prognostic impact of CI‑AKI has been observed. Some patient comorbidities and procedural characteristics have been identified as key risk factors of CI‑AKI. In this review, we discuss current evidence and future research directions on CI‑AKI prevention in patients undergoing percutaneous coronary intervention.Entities:
Mesh：
Substances：
Year: 2020 PMID： 32735406 DOI： 10.33963/KP.15537
Source DB: PubMed Journal: Kardiol Pol ISSN： 0022-9032 Impact factor: 3.108